Page last updated: 2024-09-05

substance p, sar(9)-met(o2)(11)- and aprepitant

substance p, sar(9)-met(o2)(11)- has been researched along with aprepitant in 1 studies

Compound Research Comparison

Studies
(substance p, sar(9)-met(o2)(11)-)
Trials
(substance p, sar(9)-met(o2)(11)-)
Recent Studies (post-2010)
(substance p, sar(9)-met(o2)(11)-)
Studies
(aprepitant)
Trials
(aprepitant)
Recent Studies (post-2010) (aprepitant)
15106769229521

Protein Interaction Comparison

ProteinTaxonomysubstance p, sar(9)-met(o2)(11)- (IC50)aprepitant (IC50)
Cytochrome P450 3A4Homo sapiens (human)0.046
Substance-P receptorHomo sapiens (human)0.0002
Substance-P receptorMeriones unguiculatus (Mongolian gerbil)0.0001

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Asai, H; Ishii, T; Kiuchi, S; Nagasaki, M; Okamoto, M; Saito, A; Taniguchi, H; Watanabe, Y1

Other Studies

1 other study(ies) available for substance p, sar(9)-met(o2)(11)- and aprepitant

ArticleYear
Pharmacological characterization of T-2328, 2-fluoro-4'-methoxy-3'-[[[(2S,3S)-2-phenyl-3-piperidinyl]amino]methyl]-[1,1'-biphenyl]-4-carbonitrile dihydrochloride, as a brain-penetrating antagonist of tachykinin NK1 receptor.
    Journal of pharmacological sciences, 2008, Volume: 106, Issue:1

    Topics: Animals; Antiemetics; Antineoplastic Agents; Aprepitant; Binding Sites; Brain; Cell Line, Tumor; CHO Cells; Cisplatin; Cricetinae; Cricetulus; Disease Models, Animal; Dose-Response Relationship, Drug; Ferrets; Gerbillinae; Humans; Kinetics; Male; Morpholines; Motor Activity; Neurokinin-1 Receptor Antagonists; Peptide Fragments; Piperidines; Receptors, Neurokinin-1; Substance P; Transfection; Vomiting

2008